Regarding alpha feto-protein true statement .
First, I need to recall the core concept. AFP is a fetal protein produced by the yolk sac and liver during embryonic development. It's a major tumor marker for certain conditions. The core concept here is understanding its role in prenatal screening and oncology.
The correct answer is likely related to one of the standard facts about AFP. Common true statements include its use in detecting neural tube defects, Down syndrome, or as a tumor marker for hepatocellular carcinoma and yolk sac tumors. Let's say the correct answer is that AFP is elevated in hepatocellular carcinoma. That's a high-yield fact.
Now, the wrong options might include things like being a marker for breast cancer, or being produced by the placenta, or used in Down syndrome screening (though it is used alongside other markers, but maybe the phrasing is incorrect). For each wrong option, I need to explain why they're incorrect. For example, if an option says AFP is a marker for breast cancer, that's wrong because AFP is more specific for liver and germ cell tumors.
Clinical pearl: Remember that elevated AFP levels are associated with HCC and yolk sac tumors. Also, low levels in maternal serum can indicate Down syndrome. Mnemonic: "AFP for liver and yolk, low for Down."
Putting it all together, the explanation should cover these points clearly and concisely, making sure each section is addressed as per the user's instructions. Need to check for the character limit and ensure the explanation is thorough but not too long.
**Core Concept**
Alpha-fetoprotein (AFP) is a fetal plasma protein synthesized by the yolk sac and liver during embryogenesis. It serves as a **tumor marker** for hepatocellular carcinoma (HCC) and yolk sac tumors, and as a **prenatal screening marker** for neural tube defects and Down syndrome.
**Why the Correct Answer is Right**
Elevated maternal serum AFP levels indicate **open neural tube defects** (e.g., spina bifida) or **abdominal wall defects** (e.g., gastroschisis) due to fetal leakage into amniotic fluid. In adults, AFP elevation is diagnostic for **HCC** (due to dysregulated hepatocyte proliferation) or **germ cell tumors** (e.g., yolk sac tumors). The protein is cleared postnatally, with undetectable levels by age 18 months.
**Why Each Wrong Option is Incorrect**
**Option A:** *"Produced by placenta"* β AFP is produced by the **fetal liver and yolk sac**, not the placenta. Placental alkaline phosphatase is the placental tumor marker.
**Option B:** *"Used to screen for Down syndrome in maternal serum"* β AFP is part of the **triple/quad screen** for Down syndrome but is **not diagnostic**; low AFP correlates with trisomy 21.
**Option C:** *"Elevated in breast cancer"* β AFP is **not a marker** for breast cancer. CA 15-3 or CEA are more relevant